SCHEMBL14327086

SCHEMBL14327086

CCC(CCN(C)C(=O)NC)c1cc(-c2ccc3cn(Cc4ccccc4)nc3c2)c2c(N)ncnn12

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 18/20 0.36
▸ RET P07949 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ TYRO3 Q06418 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14327061 0.87 ACVRL1 (0.36) RIPK1RETKDR
SCHEMBL14312813 0.81 ACVRL1 (0.43) RIPK1RETKDR
SCHEMBL14327088 0.80 RIPK1 (0.34) RIPK1TYRO3
SCHEMBL14531789 0.79 CFTR (0.34) RIPK1
SCHEMBL14327068 0.79 RIPK1 (0.37) RIPK1RETKDR
SCHEMBL14312500 0.78 RIPK1 (0.41) RIPK1
SCHEMBL14313418 0.77 PIK3CD (0.45) RIPK1
SCHEMBL14531365 0.77 RIPK1 (0.46) RIPK1
SCHEMBL16496878 0.76 RIPK1 (0.43) RIPK1
SCHEMBL14312723 0.76 RIPK1 (0.46) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945222-B1 PYRROLO[2,1-F] [1,2,4]-TRIAZIN-4-YLAMINES AS IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES Bayer Pharma AG (DE) 2012-12-26 — — EP disclosed
Send feedback